Study to assess the Pharmacokinetics and Safety of AZD9977 in Participants with Renal Impairment

Trial Identifier: D6401C00008
Sponsor: AstraZeneca
NCTID:: NCT04469907
Start Date: June 2020
Primary Completion Date: October 2021
Study Completion Date: October 2021
Condition: Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
NZ Christchurch, NZ, 8011
NZ Grafton, NZ, 1010
US, CA Northridge, CA, US, 91324
US, FL Deland, FL, US, 32720
US, FL Hialeah, FL, US, 33014
US, FL Hollywood, FL, US, 33024
US, FL Jacksonville, FL, US, 32216
US, FL Orlando, FL, US, 32809
US, OH Blue Ash, OH, US, 45242
US, TX San Antonio, TX, US, 78212